Arizona State Retirement System Allakos Inc. Transaction History

Arizona State Retirement System

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 06, 2023	BUY	$2.13 - $5.55 $617 - $1,609	290 Added 2.41%	12,323 $27,000
Q2 2023 Aug 01, 2023	BUY	$3.6 - $5.25 $3,322 - $4,845	923 Added 8.31%	12,033 $52,000
Q1 2023 Apr 27, 2023	SELL	$4.3 - $8.27 $29,326 - $56,401	-6,820 Reduced 38.04%	11,110 $49,000
Q4 2022 Feb 07, 2023	BUY	$5.66 - $8.42 $101,483 - $150,970	17,930 New	17,930 $150,000
Q4 2021 Feb 04, 2022	SELL	$8.55 - $111.89 $74,855 - $979,596	-8,755 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$76.53 - $110.43 $14,693 - $21,202	192 Added 2.24%	8,755 $927,000
Q2 2021 Aug 02, 2021	BUY	$85.37 - $114.1 $78,625 - $105,086	921 Added 12.05%	8,563 $731,000
Q1 2021 May 06, 2021	BUY	$109.73 - $153.66 $60,351 - $84,513	550 Added 7.76%	7,642 $877,000
Q4 2020 Jan 28, 2021	SELL	$79.58 - $152.45 $21,088 - $40,399	-265 Reduced 3.6%	7,092 $993,000
Q3 2020 Nov 05, 2020	BUY	$66.43 - $90.99 $123,559 - $169,241	1,860 Added 33.84%	7,357 $599,000
Q2 2020 Aug 04, 2020	SELL	$44.04 - $80.69 $9,468 - $17,348	-215 Reduced 3.76%	5,497 $395,000
Q1 2020 May 05, 2020	BUY	$44.49 - $93.39 $254,126 - $533,443	5,712 New	5,712 $254,000

66M

47.1K

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $22M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

Stay updated on Arizona State Retirement System with notifications on news.